Report Detail
Global Monoclonal antibodies (mAbs) Biosimilars Market Professional Survey Report 2019
- RnM3810371 |
- 09 October, 2019 |
- Global |
- 101 Pages |
- QYResearch |
- Pharma & Healthcare
A biosimilar medicine is a medicinal product of biological origin that is produced in a living organism following a procedure equivalent to a biological drug and adhering to the same quality criteria, hence the name biosimilars. In short, they are biological drugs that are “equivalent” in terms of quality, efficacy and safety to an innovative reference medicinal product.
According to the report, one driver that will lead to the growth of this market is the rise in number of patent expiries.
The global Monoclonal antibodies (mAbs) Biosimilars market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Monoclonal antibodies (mAbs) Biosimilars volume and value at global level, regional level and company level. From a global perspective, this report represents overall Monoclonal antibodies (mAbs) Biosimilars market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Monoclonal antibodies (mAbs) Biosimilars in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Monoclonal antibodies (mAbs) Biosimilars manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Biocon
Celltrion
Dr. Reddy's Laboratories
Hospira
3SBio
Accord Healthcare
AET Biotech
Allergan
Amega Biotech
Others
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Erythropoietin (EPO)
Human Growth Hormone (HGH)
Granulocyte- Colony Stimulating Factor (G-CSF)
Monoclonal Antibody (mAb)
Insulin
Interferon (IFN)
Others
Segment by Application
Anti-Cancer
Anti-Inflammatory/Autoimmune
Table of Contents
Executive Summary
1 Industry Overview of Monoclonal antibodies (mAbs) Biosimilars
- 1.1 Definition of Monoclonal antibodies (mAbs) Biosimilars
- 1.2 Monoclonal antibodies (mAbs) Biosimilars Segment by Type
- 1.2.1 Global Monoclonal antibodies (mAbs) Biosimilars Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 Erythropoietin (EPO)
- 1.2.3 Human Growth Hormone (HGH)
- 1.2.4 Granulocyte- Colony Stimulating Factor (G-CSF)
- 1.2.5 Monoclonal Antibody (mAb)
- 1.2.6 Insulin
- 1.2.7 Interferon (IFN)
- 1.2.8 Others
- 1.3 Monoclonal antibodies (mAbs) Biosimilars Segment by Applications
- 1.3.1 Global Monoclonal antibodies (mAbs) Biosimilars Consumption Comparison by Applications (2014-2025)
- 1.3.2 Anti-Cancer
- 1.3.3 Anti-Inflammatory/Autoimmune
- 1.4 Global Monoclonal antibodies (mAbs) Biosimilars Overall Market
- 1.4.1 Global Monoclonal antibodies (mAbs) Biosimilars Revenue (2014-2025)
- 1.4.2 Global Monoclonal antibodies (mAbs) Biosimilars Production (2014-2025)
- 1.4.3 North America Monoclonal antibodies (mAbs) Biosimilars Status and Prospect (2014-2025)
- 1.4.4 Europe Monoclonal antibodies (mAbs) Biosimilars Status and Prospect (2014-2025)
- 1.4.5 China Monoclonal antibodies (mAbs) Biosimilars Status and Prospect (2014-2025)
- 1.4.6 Japan Monoclonal antibodies (mAbs) Biosimilars Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Monoclonal antibodies (mAbs) Biosimilars Status and Prospect (2014-2025)
- 1.4.8 India Monoclonal antibodies (mAbs) Biosimilars Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Monoclonal antibodies (mAbs) Biosimilars
- 2.3 Manufacturing Process Analysis of Monoclonal antibodies (mAbs) Biosimilars
- 2.4 Industry Chain Structure of Monoclonal antibodies (mAbs) Biosimilars
3 Development and Manufacturing Plants Analysis of Monoclonal antibodies (mAbs) Biosimilars
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Monoclonal antibodies (mAbs) Biosimilars Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Monoclonal antibodies (mAbs) Biosimilars
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Monoclonal antibodies (mAbs) Biosimilars Production and Capacity Analysis
- 4.2 Monoclonal antibodies (mAbs) Biosimilars Revenue Analysis
- 4.3 Monoclonal antibodies (mAbs) Biosimilars Price Analysis
- 4.4 Market Concentration Degree
5 Monoclonal antibodies (mAbs) Biosimilars Regional Market Analysis
- 5.1 Monoclonal antibodies (mAbs) Biosimilars Production by Regions
- 5.1.1 Global Monoclonal antibodies (mAbs) Biosimilars Production by Regions
- 5.1.2 Global Monoclonal antibodies (mAbs) Biosimilars Revenue by Regions
- 5.2 Monoclonal antibodies (mAbs) Biosimilars Consumption by Regions
- 5.3 North America Monoclonal antibodies (mAbs) Biosimilars Market Analysis
- 5.3.1 North America Monoclonal antibodies (mAbs) Biosimilars Production
- 5.3.2 North America Monoclonal antibodies (mAbs) Biosimilars Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Monoclonal antibodies (mAbs) Biosimilars Import and Export
- 5.4 Europe Monoclonal antibodies (mAbs) Biosimilars Market Analysis
- 5.4.1 Europe Monoclonal antibodies (mAbs) Biosimilars Production
- 5.4.2 Europe Monoclonal antibodies (mAbs) Biosimilars Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Monoclonal antibodies (mAbs) Biosimilars Import and Export
- 5.5 China Monoclonal antibodies (mAbs) Biosimilars Market Analysis
- 5.5.1 China Monoclonal antibodies (mAbs) Biosimilars Production
- 5.5.2 China Monoclonal antibodies (mAbs) Biosimilars Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Monoclonal antibodies (mAbs) Biosimilars Import and Export
- 5.6 Japan Monoclonal antibodies (mAbs) Biosimilars Market Analysis
- 5.6.1 Japan Monoclonal antibodies (mAbs) Biosimilars Production
- 5.6.2 Japan Monoclonal antibodies (mAbs) Biosimilars Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Monoclonal antibodies (mAbs) Biosimilars Import and Export
- 5.7 Southeast Asia Monoclonal antibodies (mAbs) Biosimilars Market Analysis
- 5.7.1 Southeast Asia Monoclonal antibodies (mAbs) Biosimilars Production
- 5.7.2 Southeast Asia Monoclonal antibodies (mAbs) Biosimilars Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Monoclonal antibodies (mAbs) Biosimilars Import and Export
- 5.8 India Monoclonal antibodies (mAbs) Biosimilars Market Analysis
- 5.8.1 India Monoclonal antibodies (mAbs) Biosimilars Production
- 5.8.2 India Monoclonal antibodies (mAbs) Biosimilars Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Monoclonal antibodies (mAbs) Biosimilars Import and Export
6 Monoclonal antibodies (mAbs) Biosimilars Segment Market Analysis (by Type)
- 6.1 Global Monoclonal antibodies (mAbs) Biosimilars Production by Type
- 6.2 Global Monoclonal antibodies (mAbs) Biosimilars Revenue by Type
- 6.3 Monoclonal antibodies (mAbs) Biosimilars Price by Type
7 Monoclonal antibodies (mAbs) Biosimilars Segment Market Analysis (by Application)
- 7.1 Global Monoclonal antibodies (mAbs) Biosimilars Consumption by Application
- 7.2 Global Monoclonal antibodies (mAbs) Biosimilars Consumption Market Share by Application (2014-2019)
8 Monoclonal antibodies (mAbs) Biosimilars Major Manufacturers Analysis
- 8.1 Biocon
- 8.1.1 Biocon Monoclonal antibodies (mAbs) Biosimilars Production Sites and Area Served
- 8.1.2 Biocon Product Introduction, Application and Specification
- 8.1.3 Biocon Monoclonal antibodies (mAbs) Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 Celltrion
- 8.2.1 Celltrion Monoclonal antibodies (mAbs) Biosimilars Production Sites and Area Served
- 8.2.2 Celltrion Product Introduction, Application and Specification
- 8.2.3 Celltrion Monoclonal antibodies (mAbs) Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Dr. Reddy's Laboratories
- 8.3.1 Dr. Reddy's Laboratories Monoclonal antibodies (mAbs) Biosimilars Production Sites and Area Served
- 8.3.2 Dr. Reddy's Laboratories Product Introduction, Application and Specification
- 8.3.3 Dr. Reddy's Laboratories Monoclonal antibodies (mAbs) Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Hospira
- 8.4.1 Hospira Monoclonal antibodies (mAbs) Biosimilars Production Sites and Area Served
- 8.4.2 Hospira Product Introduction, Application and Specification
- 8.4.3 Hospira Monoclonal antibodies (mAbs) Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 3SBio
- 8.5.1 3SBio Monoclonal antibodies (mAbs) Biosimilars Production Sites and Area Served
- 8.5.2 3SBio Product Introduction, Application and Specification
- 8.5.3 3SBio Monoclonal antibodies (mAbs) Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 Accord Healthcare
- 8.6.1 Accord Healthcare Monoclonal antibodies (mAbs) Biosimilars Production Sites and Area Served
- 8.6.2 Accord Healthcare Product Introduction, Application and Specification
- 8.6.3 Accord Healthcare Monoclonal antibodies (mAbs) Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 AET Biotech
- 8.7.1 AET Biotech Monoclonal antibodies (mAbs) Biosimilars Production Sites and Area Served
- 8.7.2 AET Biotech Product Introduction, Application and Specification
- 8.7.3 AET Biotech Monoclonal antibodies (mAbs) Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 Allergan
- 8.8.1 Allergan Monoclonal antibodies (mAbs) Biosimilars Production Sites and Area Served
- 8.8.2 Allergan Product Introduction, Application and Specification
- 8.8.3 Allergan Monoclonal antibodies (mAbs) Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 Amega Biotech
- 8.9.1 Amega Biotech Monoclonal antibodies (mAbs) Biosimilars Production Sites and Area Served
- 8.9.2 Amega Biotech Product Introduction, Application and Specification
- 8.9.3 Amega Biotech Monoclonal antibodies (mAbs) Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
- 8.10 Others
- 8.10.1 Others Monoclonal antibodies (mAbs) Biosimilars Production Sites and Area Served
- 8.10.2 Others Product Introduction, Application and Specification
- 8.10.3 Others Monoclonal antibodies (mAbs) Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.10.4 Main Business and Markets Served
9 Development Trend of Analysis of Monoclonal antibodies (mAbs) Biosimilars Market
- 9.1 Global Monoclonal antibodies (mAbs) Biosimilars Market Trend Analysis
- 9.1.1 Global Monoclonal antibodies (mAbs) Biosimilars Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Monoclonal antibodies (mAbs) Biosimilars Regional Market Trend
- 9.2.1 North America Monoclonal antibodies (mAbs) Biosimilars Forecast 2019-2025
- 9.2.2 Europe Monoclonal antibodies (mAbs) Biosimilars Forecast 2019-2025
- 9.2.3 China Monoclonal antibodies (mAbs) Biosimilars Forecast 2019-2025
- 9.2.4 Japan Monoclonal antibodies (mAbs) Biosimilars Forecast 2019-2025
- 9.2.5 Southeast Asia Monoclonal antibodies (mAbs) Biosimilars Forecast 2019-2025
- 9.2.6 India Monoclonal antibodies (mAbs) Biosimilars Forecast 2019-2025
- 9.3 Monoclonal antibodies (mAbs) Biosimilars Market Trend (Product Type)
- 9.4 Monoclonal antibodies (mAbs) Biosimilars Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Monoclonal antibodies (mAbs) Biosimilars Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Monoclonal antibodies (mAbs) Biosimilars. Industry analysis & Market Report on Monoclonal antibodies (mAbs) Biosimilars is a syndicated market report, published as Global Monoclonal antibodies (mAbs) Biosimilars Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Monoclonal antibodies (mAbs) Biosimilars market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
